is Rs 1441.15 Glaxosmithkline Pharmaceuticals Ltd, incorporated in the year 1924, has its registered office in GSK House, Dr Annie Besant Road Worli, Mumbai, Maharashtra, 400030, 91-022-24959595 ...

GlaxoSmithKline Pharmaceuticals ... Pharma Limited was incorporated in November 13, 1924. During year 1956, the Company began primary production of vaccines at Worli. In the year 1960, the company ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

17-May-24 31-May-24 31-May-24 32 Rs.32.0000 per share(320%)Final Dividend 17-May-23 30-Jun-23 30-Jun-23 32 Rs.32.0000 per share(320%)Final Dividend 16-May-22 08-Jul-22 07-Jul-22 30 Rs.30.0000 per ...

As one of the fastest-growing major economies in the world, India has recorded a GDP growth of 7.6%* in FY 2023-24, owing to a strong rebound in economic activity. Rising disposable income levels ...

GlaxoSmithKline Pharmaceuticals Ltd is investing Rs 1,000 crore in a new state-of-the-art pharmaceutical unit in Karnataka and is looking at enhancing its global pipeline in areas like respiratory ...

For a limited time only starting Friday ... each topped with matching sanding sugar. Take a look at photos of the cakes below and check out our full guide to Wicked merchandise here!

Ambareesh Baliga of Edelweiss Financial Services is of the view that one may hold GlaxoSmithKline Pharmaceuticals as the stock may head higher. Buy CEAT, Dishman Pharmaceuticals: Angel Broking ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

GlaxoSmithKline Pharmaceuticals Ltd on Friday reported a 37.87 per cent rise in consolidated net profit at Rs 182.33 crore in the first quarter ended June 30, 2024. The company had posted a ...